From Housing Today:

As the Wall Street Journal editorial page notes, “The apparent breakthrough is a credit to the innovative capacity of the private pharmaceutical industry. Pfizer has developed the vaccine using its own capital.” And how many similar missions are there? I suppose climate change would be another one. But we don’t want to let “mission-oriented directionality” squeeze out the scientific serendipity of basic research. This from my podcast chat earlier this year with Tony Mills, director of the R Street Institute’s science policy program.